Southern California Hospital at Culver City’s Subacute Unit Receives “Above Average” for Overall Care, “Much Above Average” for Quality Measures

Southern California Hospital at Culver City’s subacute unit received four stars for quality of resident care. Four stars mean the quality of care is “above average,” according to the Centers for Medicare & Medicaid Services (CMS). In addition, the subacute unit ranked much above average (five stars) for quality measures. Our hospital ratings on appear on the government’s Nursing Home Compare website.

Every quarter, the federal agency publicly releases quality ratings for more than 15,000 nursing homes certified by Medicare and Medicaid on the Nursing Home Compare website. Each facility is given an overall rating from one star (lowest) to five stars (highest) based on health inspections, staffing levels, and quality of resident care measures. The tool was created to help consumers, their families, and caregivers more easily find nursing home care and determine whether a specific facility meets their needs.

Nursing homes vary in the quality of care and services they provide to their residents. Health inspection results, staffing data, and quality of resident care information are 3 important ways to measure the quality of a nursing homes. This information, combined in the star rating, gives you a "snapshot" of the quality of each nursing home.

The ratings show Culver City hospital’s subacute unit also is ranked much above average (five stars) for quality measures and above average (four stars) in health inspections and overall rating.

The 21-bed unit provides a level of care for individuals who no longer require acute hospitalization, but remain medically fragile and require special services. These services may include inhalation therapy, tracheotomy care, intravenous tube feeding, or complex wound management care. Currently, all residents are long-term, with some having been at the facility for up to two years.

The unit also exceeded a 90 percent staff and resident COVID vaccine primary series rate for four consecutive weeks during the fourth quarter of 2021.